Adolescence' promotes a political agenda, and the narrative is about toxic masculinity with a 13-year-old child at its center.

US-based biopharmaceutical company Helicore Biopharma has dosed the first subject in a randomised, first-in-human Phase I trial of its humanised monoclonal antibody HCR-188 to treat obesity. The study ...